Research

Energy balance

Discontinuation rates due to adverse effects were 10.3% for Semaglutide and 8.3% for Liraglutide.

Practitioners should consider these discontinuation rates when evaluating treatment options.

StrongSupportsmedium confidence
Discontinuation rates due to adverse effects were 10.3% for Semaglutide and 8.3% for Liraglutide.
Pranjal Sharma et al. · Endocrines · 2024

Why this rating

Based on systematic review of studies.

Source

Glucagon-like Peptide-1 Receptor Agonists: Are They as Good as They Seem? A Systematic Review of Severe Adverse Effects

Pranjal Sharma et al. · Endocrines · 2024

DOI 10.3390/endocrines5030023

Meta-analysisCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →